Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients

Immunity, Inflammation and Disease

Volumn 5, Issue 3, 2017, Pages 244-260

  D’Ettorre, Gabriella ^a   Rossi, Giacomo ^b   Scagnolari, Carolina ^c   Andreotti, Mauro ^d   Giustini, Noemi ^c   Serafino, Sara ^c   Schietroma, Ivan ^c   Corano Scheri, Giuseppe ^c   Najafi Fard, Saeid ^c   Trinchieri, Vito ^c   Mastromarino, Paola ^c   Selvaggi, Carla ^c   Scarpona, Silvia ^b   Fanello, Gianfranco ^e   Fiocca, Fausto ^e   Ceccarelli, Giancarlo ^a   Antonelli, Guido ^c   Brenchley, Jason M ^f   Vullo, Vincenzo ^c  

^a POLICLINICO UMBERTO I   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Italian Health Institute   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Apoptosis; GALT; GUT; HIV 1; HSP60; IELs; Immunity; Probiotics; T cell activation; Tc1; Tc17; Th1; Th17

Indexed keywords

ANTIRETROVIRUS AGENT; PROBIOTIC AGENT;

ADULT; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INTESTINE MUCOSA; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MITOCHONDRION; PATHOLOGY; TH1 CELL; TH17 CELL;

ADULT; ANTI-RETROVIRAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; HIV SEROPOSITIVITY; HIV-1; HUMANS; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MITOCHONDRIA; PROBIOTICS; TH1 CELLS; TH17 CELLS;

EID: 85036664973     PISSN: None     EISSN: 20504527     Source Type: Journal    
DOI: 10.1002/iid3.160     Document Type: Article

References (62)

1. Marchetti, G., C. Tincati, and G. Silvestri. 2013. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin. Microbiol. Rev. 26:2-18.
2. Sandler, N. G., and D. C. Douek. 2012. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat. Rev. Microbiol. 10:655-666.
3. Klatt, N. R., and J. M. Brenchley. 2010. Th17 cell dynamics in HIV infection. Curr. Opin. HIV AIDS 5:135-140.
4. Estes, J. D., L. D. Harris, N. R. Klatt, B. Tabb, S. Pittaluga, M. Paiardini, G. R. Barclay, J. Smedley, R. Pung, K. M. Oliveira, et al. 2010. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 6:e1001052.
5. Paiardini, M. 2010. Th17 cells in natural SIV hosts. Curr. Opin. HIV AIDS 5:166-172.
6. Cecchinato, V., and G. Franchini. 2010. Th17 cells in pathogenic simian immunodeficiency virus infection of macaques. Curr. Opin. HIV AIDS 5:141-145.
7. Dillon, S. M., E. J. Lee, A. M. Donovan, K. Guo, M. S. Harper, D. N. Frank, M. D. McCarter, M. L. Santiago, and C. C. Wilson. 2016. Enhancement of HIV-1 infection and intestinal CD4+ T cell depletion ex vivo by gut microbes altered during chronic HIV-1 infection. Retrovirology 13:5.
8. Lozupone, C. A., M. Li, T. B. Campbell, S. C. Flores, D. Linderman, M. J. Gebert, R. Knight, A. P. Fontenot, and B. E. Palmer. 2013. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host. Microbe 14:329-339.
9. Dillon, S. M., E. J. Lee, C. V. Kotter, G. L. Austin, Z. Dong, D. K. Hecht, S. Gianella, B. Siewe, D. M. Smith, A. L. Landay, et al. 2014. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal. Immunol. 7:983-994.
10. Zevin, A. S., L. McKinnon, A. Burgener, and N. R. Klatt. 2016. Microbial translocation and microbiome dysbiosis in HIVassociated immune activation. Curr. Opin. HIV AIDS 11:182-190.
11. Klatt, N. R., L. A. Canary, X. Sun, C. L. Vinton, N. T. Funderburg, D. N. R. Morcock, M. Quiñones, C. B. Deming, M. Perkins, D. J. Hazuda, et al. 2013. Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. J. Clin. Invest. 123: 903-907.
12. Ortiz, A. M., Z. A. Klase, S. R. DiNapoli, I. Vujkovic-Cvijin, K. Carmack, M. R. Perkins, N. Calantone, C. L. Vinton, N. E. Riddick, J. Gallagher, et al. 2016. IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques. Mucosal Immunol. 9:458-467.
13. Vujkovic-Cvijin, I., L. A. Swainson, S. N. Chu, A. M. Ortiz, C. A. Santee, A. Petriello, R. M. Dunham, D. W. Fadrosh, D. L. Lin, A. A. Faruqi, et al. 2015. Gut-resident Lactobacillus abundance associates with IDO1 inhibition and Th17 dynamics in SIV-infected macaques. Cell. Rep. 13:1589-1597.
14. Falasca, K., J. Vecchiet, C. Ucciferri, M. Di Nicola, C. D’Angelo, and M. Reale. 2015. Effect of probiotic supplement on cytokine levels in HIV-infected individuals. A preliminary study. Nutrients 7:8335-8347.
15. d’Ettorre, G., G. Ceccarelli, N. Giustini, S. Serafino, N. Calantone, G. De Girolamo, L. Bianchi, V. Bellelli, T. Ascoli-Bartoli, S. Marcellini, et al. 2015. Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: results of the ‘‘probio-HIV’’ clinical trial. PLoS ONE 10: e0137200.
16. Stiksrud, B., P. Nowak, F. C. Nwosu, D. Kvale, A. Thalme, A. Sonnerborg, P. M. Ueland, K. Holm, S. E. Birkeland, A. E. Dahm, et al. 2015. Reduced levels of D-dimer and changes in gut microbiota composition after probiotic intervention in HIV-infected individuals on stable ART. J. Acquir. Immune Defic. Syndr. 70:329-3337.
17. Villar-García, J., J. J. Hernández, R. Güerri-Fernández, A. González, E. Lerma, A. Guelar, D. Saenz, L. Sorlí, M. Montero, P. J. Horcajada, et al. 2015. Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial. J. Acquir. Immune Defic. Syndr. 68:256-263.
18. Yang, O. O., T. Kelesidis, R. Cordova, and H. Khanlou. 2014. Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial. AIDS Res. Hum. Retroviruses 30:988-995.
19. Schunter, M., H. Chu, T. L. Hayes, D. McConnell, S. S. Crawford, P. A. Luciw, S. Bengmark, D. M. Asmuth, J. Brown, C. L. Bevins, et al. 2012. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection. BMC Complement. Altern. Med. 12:84.
20. Cunningham-Rundles, S., S. Ahrné, R. Johann-Liang, R. Abuav, A.-M. Dunn-Navarra, C. Grassey, S. Bengmark, and J. S. Cervia. 2011. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Nutrients 3: 1042-1070.
21. d’Ettorre, G., S. Baroncelli, L. Micci, G. Ceccarelli, M. Andreotti, P. Sharma, G. Fanello, F. Fiocca, E. N. Cavallari, N. Giustini, et al. 2014. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIVinfected subjects: implication for residual immune activation from the results of a clinical trial. PLoS ONE 9:e109791.
22. Nowak, P., M. Troseid, E. Avershina, B. Barqasho, U. Neogi, K. Holm, J. R. Hov, K. Noyan, J. Vesterbacka, J. Svärd, et al. 2015. Gut microbiota diversity predicts immune status in HIV-1 infection. AIDS Lond. Engl. 29:2409-2418.
23. Dinh, D. M., G. E. Volpe, C. Duffalo, S. Bhalchandra, A. K. Tai, A. V. Kane, C. A. Wanke, and H. D. Ward. 2015. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J. Infect. Dis. 211: 19-27.
24. Sanders, M. E., L. M. A. Akkermans, D. Haller, C. Hammerman, J. Heimbach, G. Hörmannsperger, G. Huys, D. D. Levy, F. Lutgendorff, D. Mack, et al. 2010. Safety assessment of probiotics for human use. Gut Microbes 1:164-185.
25. Ganji-Arjenaki M., and M. Rafieian-Kopaei. 2017. Probiotics are a good choice in remission of inflammatory bowel diseases: a meta analysis and systematic review. J. Cell Physiol. https://doi.org/10.1002/jcp.25911 [Epub ahead of print].
26. Gionchetti, P., F. Rizzello, A. Venturi, and M. Campieri. 2000. Probiotics in infective diarrhoea and inflammatory bowel diseases. J. Gastroenterol. Hepatol. 15:489-493.
27. Scagnolari, C., G. Corano Scheri, C. Selvaggi, I. Schietroma, S. Najafi Fard, A. Mastrangelo, N. Giustini, S. Serafino, C. Pinacchio, P. Pavone, et al. 2016. Probiotics differently affect gut-associated lymphoid tissue indolamine-2, 3-dioxygenase mRNA and cerebrospinal fluid neopterin levels inantiretroviral-treated HIV-1 infected patients: a pilot study. Int. J. Mol. Sci. 17.
28. Mastromarino, P., D. Capobianco, G. Campagna, N. Laforgia, P. Drimaco, A. Dileone, and M. E. Baldassarre. 2014. Correlation between lactoferrin and beneficial microbiota in breast milk and infant’s feces. Biometals 27:1077-1086.
29. Matsuki, T., K. Watanabe, J. Fujimoto, T. Takada, and R. Tanaka. 2004. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl. Environ. Microbiol. 70:7220-7228.
30. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. 2005. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J. Pediatr. Gastroenterol. Nutr. 41:1-7.
31. Cersini, A., M. C. Martino, I. Martini, G. Rossi, and M. L. Bernardini. 2003. Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutants. Infect. Immun. 71:7002-7013.
32. Lorè, N. I., C. Cigana, C. Riva, I. De Fino, A. Nonis, L. Spagnuolo, B. Sipione, L. Cariani, D. Girelli, G. Rossi, et al. 2016. IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa. Sci. Rep. 6:25937.
33. Dixon, M. F., R. M. Genta, J. H. Yardley, and P. Correa. 1996. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 20:1161-1181.
34. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1999. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119: 493-501.
35. Ciccocioppo, R., A. Di Sabatino, R. Parroni, P. Muzi, S. D’Alò, T. Ventura, M. A. Pistoia, M. G. Cifone, and G. R. Corazza. 2001. Increased enterocyte apoptosis and Fas-Fas ligand system in celiac disease. Am. J. Clin. Pathol. 115: 494-503.
36. Levillain, O., S. Balvay, and S. Peyrol. 2005. Mitochondrial expression of arginase II in male and female rat inner medullary collecting ducts. J. Histochem. Cytochem. 53: 533-541.
37. Harris, L. D., N. R. Klatt, C. Vinton, J. A. Briant, B. Tabb, K. Ladell, J. D. Estes, D. A. Price, and V. M. Hirsch. 2010. Mechanisms underlying γδ T-cell subset perturbations in SIV-infected Asian rhesus macaques. Blood 116:4148-4157.
38. Favre, D., S. Lederer, B. Kanwar, Z. M. Ma, S. Proll, Z. Kasakow, J. Mold, L. Swainson, J. D. Barbour, C. R. Baskin, et al. 2009. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog. 5:e1000295.
39. Brenchley, J. M., M. Paiardini, K. S. Knox, A. I. Asher, B. Cervasi, T. E. Asher, P. Scheinberg, D. A. Price, C. A. Hage, L. M. Kholi, et al. 2008. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112:2826-2835.
40. Raffatellu, M., R. L. Santos, D. E. Verhoeven, M. D. George, R. P. Wilson, S. E. Winter, I. Godinez, S. Sankaran, T. A. Paixao, M. A. Gordon, et al. 2008. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat. Med. 14: 421-428.
41. Manuzak, J. A., T. Hensley-McBain, A. S. Zevin, C. Miller, R. Cubas, B. Agricola, J. Gile, L. Richert-Spuhler, G. Patilea, J. D. Estes, et al. 2016. Enhancement of microbiota in healthy macaques results in beneficial modulation of mucosal and systemic immune function. J. Immunol. 196:2401-2409.
42. Abernethy, N. J., J. B. Hay, W. G. Kimpton, E. Washington, and R. N. Cahill. 1991. Lymphocyte subset-specific and tissue-specific lymphocyte-endothelial cell recognition mechanisms independently direct the recirculation of lymphocytes from blood to lymph in sheep. Immunology 72:239-245.
43. Veazey, R. S., M. DeMaria, L. V. Chalifoux, D. E. Shvetz, D. R. Pauley, H. L. Knight, M. Rosenzweig, R. P. Johnson, R. C. Desrosiers, and A. A. Lackner. 1998. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280:427-443.
44. Kraal, D., I. L. Weissman, and E. C. Butcher. 1983. Difference in vivo distribution and homing ofT cell subsets to mucosal vs nonmucosal lymphoid organs. J. Immunol. 130:1097-1118.
45. Pals, S. T., G. Kraal, E. Horst, A. De Groot, R. J. Scheper, and C. J. Meijer. 1986. Human lymphocyte-high endothelial venule interaction: organ-selective binding of T and B lymphocyte populations to high endothelium. J. Immunol. 137:760.
46. Mehandru, S., M. A. Poles, K. Tenner-Racz, P. Jean-Pierre, V. Manuelli, P. Lopez, A. Shet, A. Low, H. Mohri, D. Boden, et al. 2006. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med. 3:e484.
47. Mavigner, M., M. Cazabat, M. Dubois, F.-E. L’Faqihi, M. Requena, C. Pasquier, P. Klopp, J. Amar, L. Alric, K. Barange, et al. 2012. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J. Clin. Invest. 122:62-69.
48. Nigam, P., S. Kwa, V. Velu, and R. R. Amara. 2011. Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection. J. Immunol. 186:745-753.
49. Xu, H., X. Wang, D. X. Liu, T. Moroney-Rasmussen, A. A. Lackner, and R. S. Veazey. 2012. IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques. Mucosal Immunol. 5:658-669.
50. Cello, J. P., and L. W. Day. 2009. Idiopathic AIDS enteropathy and treatment of gastrointestinal opportunistic pathogens. Gastroenterology 136:1952-1965.
51. Kamat, A., P. Ancuta, R. S. Blumberg, and D. Gabuzda. 2010. Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation. PLoS ONE 5:e15533.
52. Pellecchia, P., and L. J. Brandt., 2010. Intestinal abnormalities in AIDS. Pp. 753-65 in M. Classen, G. N. J. Tytgat, and C. J. Lightdale, eds. Gastroenterological endoscopy. Thieme, Stuttgart, Germany.
53. Ullrich, R., M. Zeitz, W. Heise, M. L’age, G. Höffken, and E. O. Riecken. 1989. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann. Intern. Med. 111:15-21.
54. Mattapallil, J. J., Z. Smit-McBride, M. McChesney, and S. Dandekar. 1998. Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1beta expression and display antiviral cytotoxic activity despite severe CD4(+) Tcell depletion in primary simian immunodeficiency virus infection. J. Virol. 72:6421-6429.
55. Lundqvist, C., V. Baranov, K. Söderström, L. Athlin, R. Kiessling, S. Hammarström, and M. L. Hammarström. 1995. Phenotype and cytokine profile of intraepithelial lymphocytes in human small and large intestine. Ann. N. Y. Acad. Sci. 756:395-399.
56. Targan, S. R., S. B. Hanauer, S. J. van Deventer, L. Mayer, D. H. Present, T. Braakman, K. L. DeWoody, T. F. Schaible, and P. J. Rutgeerts. 1997. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s Disease cA2 Study Group. N. Engl. J. Med. 337:1029-1035.
57. Mogilner, J. G., I. Srugo, M. Lurie, R. Shaoul, A. G. Coran, E. Shiloni, and I. Sukhotniket. 2007. Effect of probiotics on intestinal regrowth and bacterial translocation after massive small bowel resection in a rat. J. Pediatr. Surg. 42:1365-1371.
58. Buccigrossi, V., G. Laudiero, E. Nicastro, E. Miele, F. Esposito, and A. Guarino. 2011. The HIV-1 transactivator factor (Tat) induces enterocyte apoptosis through a redoxmediated mechanism. PLoS ONE 6:e29436.
59. D’Souza, A., L. Fordjour, A. Ahmad, C. Cai, D. Kumar, G. Valencia, J. V. Aranda, and K. D. Beharry. 2010. Effects of probiotics, prebiotics, and synbiotics on messenger RNA expression of caveolin-1, NOS, and genes regulating oxidative stress in the terminal ileum of formula-fed neonatal rats. Pediatr. Res. 67:526-531.
60. Chandra, D., G. Choy, and D. G. Tang. 2007. Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: evidence that its proapoptotic or pro-survival functions involve differential interactions with caspase-3. J. Biol. Chem. 282:31289-31301.
61. Möbius, J., S. Groos, A. Meinhardt, and J. Seitz. 1997. Differential distribution of the mitochondrial heat-shock protein 60 in rat gastrointestinal tract. Cell Tissue Res. 287:343-350.
62. Tomasello, G., V. Rodolico, M. Zerilli, A. Martorana, F. Bucchieri, A. Pitruzzella, A. Marino Gammazza, S. David, F. Rappa, G. Zummo, et al. 2011. Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitis. Appl. Immunohistochem. Mol. Morphol. 19:552-561.